RT Journal Article
SR Electronic
T1 Treatment of obstructive and central sleep apnoea in heart failure: practical options
JF European Respiratory Review
JO EUROPEAN RESPIRATORY REVIEW
FD European Respiratory Society
SP 183
OP 188
DO 10.1183/09059180.00010607
VO 16
IS 106
A1 S. Javaheri
YR 2007
UL http://err.ersjournals.com/content/16/106/183.abstract
AB Sleep apnoea, both central and obstructive disordered breathing, commonly occurs in patients with heart failure. Obstructive sleep apnoea occurs both in systolic and diastolic heart failure and is best treated with nasal positive airway pressure devices. Central sleep apnoea occurs primarily in systolic heart failure and therapeutic options are evolving. Optimal therapy of systolic heart failure, nocturnal use of supplemental oxygen, theophylline, acetazolamide and positive airway pressure devices have been shown to improve central sleep apnoea. Among these therapeutic modalities only continuous positive airway pressure has been studied in a long-term trials; unfortunately, it failed to improve survival.